ZGU-28392-51992
3 vaccinations
4 coded responses
25 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Moderna
-
2021-01-05
Registered in v-safe
-
2021-01-06
Survey response — days 1–6 daily, dose 1MedDRA: Injection site vesicles — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Blister at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-11
- 2021-01-18
- 2021-01-25
-
2021-02-01
Dose 2 — Moderna
- 2021-02-01
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Blister — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Blisters near injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body achesAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Muscle or body achesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-08
- 2021-02-15
- 2021-02-23
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-05-03
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Headache — Feeling: GoodFree text: More frequent and higher intensity headachesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-09
Dose 3 — Moderna
- 2022-02-01
- 2022-03-10
- 2022-06-09
-
2022-12-09
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Had Covid end of june.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-13
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-01 | Moderna | |
| 3 | 2021-12-09 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-09 | Successful 2022-12-13 |
Completed over the phone |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Blister at the injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Blisters near injection site
Release 9 — 6 months, dose 2
Symptoms: More frequent and higher intensity headaches
Release 12 — 12 months, dose 3
Symptoms: Had Covid end of june.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SRO | Blister | ✓ | ✓ | ✓ |
| SRO | Injection site vesicles | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release